BHC Relative Valuation
BHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BHC is overvalued; if below, it's undervalued.
Historical Valuation
Bausch Health Companies Inc (BHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.81 is considered Undervalued compared with the five-year average of 3.30. The fair price of Bausch Health Companies Inc (BHC) is between 20.87 to 35.63 according to relative valuation methord. Compared to the current price of 7.38 USD , Bausch Health Companies Inc is Undervalued By 64.64%.
Relative Value
Fair Zone
20.87-35.63
Current Price：7.38
64.64%
Undervalued
1.81
PE
1Y
3Y
5Y
Trailing
Forward
6.28
EV/EBITDA
Bausch Health Companies Inc. (BHC) has a current EV/EBITDA of 6.28. The 5-year average EV/EBITDA is 8.04. The thresholds are as follows: Strongly Undervalued below 5.81, Undervalued between 5.81 and 6.93, Fairly Valued between 9.16 and 6.93, Overvalued between 9.16 and 10.27, and Strongly Overvalued above 10.27. The current Forward EV/EBITDA of 6.28 falls within the Undervalued range.
6.66
EV/EBIT
Bausch Health Companies Inc. (BHC) has a current EV/EBIT of 6.66. The 5-year average EV/EBIT is 8.78. The thresholds are as follows: Strongly Undervalued below 6.12, Undervalued between 6.12 and 7.45, Fairly Valued between 10.11 and 7.45, Overvalued between 10.11 and 11.44, and Strongly Overvalued above 11.44. The current Forward EV/EBIT of 6.66 falls within the Undervalued range.
0.25
PS
Bausch Health Companies Inc. (BHC) has a current PS of 0.25. The 5-year average PS is 0.53. The thresholds are as follows: Strongly Undervalued below -0.24, Undervalued between -0.24 and 0.15, Fairly Valued between 0.92 and 0.15, Overvalued between 0.92 and 1.31, and Strongly Overvalued above 1.31. The current Forward PS of 0.25 falls within the Historic Trend Line -Fairly Valued range.
1.37
P/OCF
Bausch Health Companies Inc. (BHC) has a current P/OCF of 1.37. The 5-year average P/OCF is 4.01. The thresholds are as follows: Strongly Undervalued below -3.60, Undervalued between -3.60 and 0.21, Fairly Valued between 7.81 and 0.21, Overvalued between 7.81 and 11.61, and Strongly Overvalued above 11.61. The current Forward P/OCF of 1.37 falls within the Historic Trend Line -Fairly Valued range.
1.71
P/FCF
Bausch Health Companies Inc. (BHC) has a current P/FCF of 1.71. The 5-year average P/FCF is 2.26. The thresholds are as follows: Strongly Undervalued below -0.50, Undervalued between -0.50 and 0.88, Fairly Valued between 3.64 and 0.88, Overvalued between 3.64 and 5.02, and Strongly Overvalued above 5.02. The current Forward P/FCF of 1.71 falls within the Historic Trend Line -Fairly Valued range.
Bausch Health Companies Inc (BHC) has a current Price-to-Book (P/B) ratio of -4.85. Compared to its 3-year average P/B ratio of -3.02 , the current P/B ratio is approximately 60.36% higher. Relative to its 5-year average P/B ratio of -12.28, the current P/B ratio is about -60.53% higher. Bausch Health Companies Inc (BHC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 21.22%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 15.36% , the current FCF yield is about -100.00% lower.
-4.85
P/B
Median3y
-3.02
Median5y
-12.28
41.92
FCF Yield
Median3y
21.22
Median5y
15.36
Competitors Valuation Multiple
The average P/S ratio for BHC's competitors is 0.00, providing a benchmark for relative valuation. Bausch Health Companies Inc Corp (BHC) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 6.81%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BHC decreased by 8.44% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 2.07 to 7.64.
The secondary factor is the Revenue Growth, contributed 6.81%to the performance.
Overall, the performance of BHC in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Bausch Health Companies Inc (BHC) currently overvalued or undervalued?
What is Bausch Health Companies Inc (BHC) fair value?
How does BHC's valuation metrics compare to the industry average?
What is the current P/B ratio for Bausch Health Companies Inc (BHC) as of Dec 05 2025?
What is the current FCF Yield for Bausch Health Companies Inc (BHC) as of Dec 05 2025?
What is the current Forward P/E ratio for Bausch Health Companies Inc (BHC) as of Dec 05 2025?